4.7 Article

Synergistic Effects of Long-Term Antioxidant Diet and Behavioral Enrichment on β-Amyloid Load and Non-Amyloidogenic Processing in Aged Canines

Journal

JOURNAL OF NEUROSCIENCE
Volume 30, Issue 29, Pages 9831-9839

Publisher

SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.6194-09.2010

Keywords

-

Categories

Funding

  1. National Institutes of Health/National Institute on Aging [AG12694, AG17066]
  2. U.S. Department of the Army [DAMD17-98-1-8622]

Ask authors/readers for more resources

A long-term intervention (2.69 years) with an antioxidant diet, behavioral enrichment, or the combined treatment preserved and improved cognitive function in aged canines. Although each intervention alone provided cognitive benefits, the combination treatment was additive. We evaluate the hypothesis that antioxidants, enrichment, or the combination intervention reduces age-related beta-amyloid (A beta) neuropathology, as one mechanism mediating observed functional improvements. Measures assessed were A beta neuropathology in plaques, biochemically extractable A beta(40) and A beta(42) species, soluble oligomeric forms of A beta, and various proteins in the beta-amyloid precursor protein (APP) processing pathway. The strongest and most consistent effects on A beta pathology were observed in animals receiving the combined antioxidant and enrichment treatment. Specifically, A beta plaque load was significantly decreased in several brain regions, soluble A beta(42) was decreased selectively in the frontal cortex, and a trend for lower A beta oligomer levels was found in the parietal cortex. Reductions in A beta may be related to shifted APP processing toward the non-amyloidogenic pathway, because alpha-secretase enzymatic activity was increased in the absence of changes in beta-secretase activity. Although enrichment alone had no significant effects on A beta, reduced A beta load and plaque maturation occurred in animals receiving antioxidants as a component of treatment. A beta measures did not correlate with cognitive performance on any of the six tasks assessed, suggesting that modulation of A beta alone may be a relatively minor mechanism mediating cognitive benefits of the interventions. Overall, the data indicate that multidomain treatments may be a valuable intervention strategy to reduce neuropathology and improve cognitive function in humans.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available